Clinical Trial

Microbiota in Urine and Urothelium Can be a Factor for Induction of Urinary Bladder Cancer. The Study Will Examine Urine and Bladder Cancer Tissues From Male Patients and Urine of Controls Using Whole Genomic Sequencing Techniques and 16S rRNA. The Aim is to Elucidate Role of Microbiota in Bladder

Study acronym: Cancer bladder
Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 1, 2024 (before its estimated April 2026 completion). Its status may not reflect the trial's current state.
Summary
Microbes inhabiting the urinary tract that are playing an important role in maintenance of health and the development of diseases and bladder cancer. There is correlation between initiation of bladder cancer and microbes. Urine and bladder tissues from healthy individuals and patients with bladder cancer were analyzed using 16S rRNA sequencing, results show abundant phylum. Next-generation sequencing technologies will be applied with whole genomic and 16S ribosomal RNA gene sequencing for microbiota profiling in urine and bladder tissue of male healthy individuals and patients with bladder cancer. Results will lead to prevention, diagnosis and new treatment strategies for bladder cancer.
Trial Details
NCT Number NCT06289283
Lead Sponsor Theodor Bilharz Research Institute
Conditions Urinary Bladder Neoplasms, Microtia
Enrollment 38 participants
Start Date 2023-10-12
Primary Completion 2026-04 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2024-03-01